Showing results (1-10 of 164) with videos related to
Sort By:
Pageof 17
Journal of Clinical Medicine Research|September 16, 2017
The Low-Dose (7.5 mg/day) Pioglitazone TherapyHidekatsu Yanai, Hiroki AdachiJournal of Clinical Medicine Research|June 22, 2012
The Underlying Mechanisms for Olanzapine-induced HypertriglyceridemiaHiroki Adachi, Hidekatsu Yanai, Yuji HirowatariCardiology Research|November 21, 2022
Chronic Kidney Disease Stage G4 in a Diabetic Patient Improved by Multi-Disciplinary Treatments Based Upon Literature Search for Therapeutic EvidenceHidekatsu Yanai, Naoki Yamaguchi, Hiroki AdachiGastroenterology Research|September 11, 2023
A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With HypertriglyceridemiaHisayuki Katsuyama, Hidekatsu Yanai, Hiroki Adachi, et al.International Journal of Molecular Sciences|November 11, 2022
Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease RiskHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.Cardiology Research|March 10, 2023
Glucagon-Like Peptide 1 Receptor Agonists Versus Sodium-Glucose Cotransporter 2 Inhibitors for Atherosclerotic Cardiovascular Disease in Patients With Type 2 DiabetesHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.Journal of Clinical Medicine Research|May 1, 2018
Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin TherapyMariko Hakoshima, Hidekatsu Yanai, Kouki Kakuta, et al.Journal of Clinical Medicine Research|October 24, 2025
Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 DiabetesHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.Molecules (Basel, Switzerland)|January 8, 2025
Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 DiabetesHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.International Journal of Molecular Sciences|September 28, 2023
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and TreatmentsHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.Pageof 17